WHO-GMP Certified Commercial Pack · Product Code: AKP-028
Adapalene 0.1% & Clindamycin 1.0% Gel
Formulation Overview: Comedolytic third-generation retinoid and topical antibiotic combination gel normalizing follicular epithelial differentiation while suppressing acne bacterial colonization. Formulated with Adapalene USP 0.1% w/w + Clindamycin Phosphate (eq. 1.0% w/w) (0.1% + 1.0% w/w) in Topical Anti-Acne Gel dosage form under Dermatology & Topicals, manufactured to IP / BP / USP Compendial standards and supplied in 15g / 20g Laminated Squeeze Tube with Carton with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-028 |
|---|---|
| Therapeutic Sector | Dermatology & Topicals |
| Dosage Form | Topical Anti-Acne Gel |
| Active Ingredient | Adapalene USP 0.1% w/w + Clindamycin Phosphate (eq. 1.0% w/w) |
| Strength / Purity | 0.1% + 1.0% w/w |
| Clinical Indication | Comedonal and inflammatory acne vulgaris with papulopustular lesions |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 15g / 20g Laminated Squeeze Tube with Carton |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from freezing and direct sunlight |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |